On Friday, scPharmaceuticals Inc (NASDAQ: SCPH) was 15.14% up from the session before settling in for the closing price of $2.02. A 52-week range for SCPH has been $1.94 – $5.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 33.46% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 48.68%. With a float of $34.26 million, this company’s outstanding shares have now reached $50.10 million.
In an organization with 164 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 68.59%, operating margin of -178.29%, and the pretax margin is -234.36%.
scPharmaceuticals Inc (SCPH) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward scPharmaceuticals Inc stocks. The insider ownership of scPharmaceuticals Inc is 31.88%, while institutional ownership is 64.96%. The most recent insider transaction that took place on Aug 13 ’24, was worth 2,000,000. In this transaction 10% Owner of this company bought 500,000 shares at a rate of $4.00, taking the stock ownership to the 5,806,670 shares.
scPharmaceuticals Inc (SCPH) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.68% per share during the next fiscal year.
scPharmaceuticals Inc (NASDAQ: SCPH) Trading Performance Indicators
You can see what scPharmaceuticals Inc (SCPH) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of scPharmaceuticals Inc (SCPH)
Let’s dig in a bit further. During the last 5-days, its volume was 0.66 million. That was better than the volume of 0.44 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 29.44%. Additionally, its Average True Range was 0.25.
During the past 100 days, scPharmaceuticals Inc’s (SCPH) raw stochastic average was set at 19.74%, which indicates a significant decrease from 31.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 108.05% in the past 14 days, which was higher than the 61.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.03, while its 200-day Moving Average is $3.92. However, in the short run, scPharmaceuticals Inc’s stock first resistance to watch stands at $2.43. Second resistance stands at $2.53. The third major resistance level sits at $2.75. If the price goes on to break the first support level at $2.11, it is likely to go to the next support level at $1.89. Assuming the price breaks the second support level, the third support level stands at $1.79.
scPharmaceuticals Inc (NASDAQ: SCPH) Key Stats
There are 50,284K outstanding shares of the company, which has a market capitalization of 116.65 million. As of now, sales total 36,330 K while income totals -85,150 K. Its latest quarter income was 12,150 K while its last quarter net income were -18,850 K.
